DAF in diabetic patients is subject to glycation/inactivation at its active site residues.

about

DAF in diabetic patients is subject to glycation/inactivation at its active site residues.

Item

http://www.wikidata.org/entity/Q47832785

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

DAF in diabetic patients is su ...... n at its active site residues.

@en

DAF in diabetic patients is su ...... n at its active site residues.

@nl

type

Item

label

DAF in diabetic patients is su ...... n at its active site residues.

@en

DAF in diabetic patients is su ...... n at its active site residues.

@nl

prefLabel

DAF in diabetic patients is su ...... n at its active site residues.

@en

DAF in diabetic patients is su ...... n at its active site residues.

@nl

P1476

DAF in diabetic patients is su ...... n at its active site residues.

@en

P2093

Enzo Cocuzzi

http://www.w3.org/2001/XMLSchema#string

M Edward Medof

http://www.w3.org/2001/XMLSchema#string

Menachem Shoham

http://www.w3.org/2001/XMLSchema#string

Ram H Nagaraj

http://www.w3.org/2001/XMLSchema#string

Rudolf Flückiger

http://www.w3.org/2001/XMLSchema#string

Timothy S Kern

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement

Solution structure of a functionally active fragment of decay-accelerating factor

Complement regulation at the molecular level: The structure of decay-accelerating factor

Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor

Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels.

Complement regulators in human disease: lessons from modern genetics.

Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts.

Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.

P304

246-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLIMM.2017.06.036

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28886871

http://www.w3.org/2001/XMLSchema#string

P932

5884443

http://www.w3.org/2001/XMLSchema#string